A Safety Extension Study of DR-OXY-301
Public ClinicalTrials.gov record NCT00782769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Parallel-Group Extension Study to Evaluate the Safety of Two Doses of DR-3001 in Women With Overactive Bladder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a safety extension study of DR-OXY-301 at pre-selected sites. Subjects who complete the DR-OXY-301 study are eligible to participate. The duration of this extension study will be up to approximately 42 weeks. Subjects will have physical and laboratory exams, including blood draws at each scheduled visit and colposcopic examination of the vagina and cervix. As in DR-OXY-301, subjects will be required to insert a vaginal ring; replacing it every 4 weeks. Subjects will also be required to keep a daily record of the number of times and the total amount of time the ring was outside the body each day and the reason for voluntary removal.
Study identification
- NCT ID
- NCT00782769
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2008 (Type not available)
- Primary completion
- Jul 2010 (Actual)
- Completion
- Jul 2010 (Actual)
- Last update posted
- Mar 16, 2023
2008 – 2010
United States locations
- U.S. sites
- 35
- U.S. states
- 23
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Duramed Investigational Site | Phoenix | Arizona | 85015 | — |
| Duramed Investigational Site | San Diego | California | 92103 | — |
| Duramed Investigational Site | San Diego | California | 92108 | — |
| Duramed Investigational Site | Miami | Florida | 33143 | — |
| Duramed Investigational Site | Tampa | Florida | 33607 | — |
| Duramed Investigational Site | Augusta | Georgia | 30901 | — |
| Duramed Investigational Site | Savannah | Georgia | 31406 | — |
| Duramed Investigational Site | Boise | Idaho | 83712 | — |
| Duramed Investigational Site | Chicago | Illinois | 60661-3095 | — |
| Duramed Investigational Site | Wichita | Kansas | 67207 | — |
| Duramed Investigational Site | Louisville | Kentucky | 40291 | — |
| Duramed Investigational Site | Watertown | Massachusetts | 02472 | — |
| Duramed Investigational Site | Las Vegas | Nevada | 89030 | — |
| Duramed Investigational Site | Las Vegas | Nevada | 89109 | — |
| Duramed Investigational Site | Las Vegas | Nevada | 89128 | — |
| Duramed Investigational Site | Moorestown | New Jersey | 08057 | — |
| Duramed Investigational Site | Albuquerque | New Mexico | 87102 | — |
| Duramed Investigational Site | Port Jefferson | New York | 11777 | — |
| Duramed Investigational Site | New Bern | North Carolina | 28562 | — |
| Duramed Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Duramed Investigational Site | Eugene | Oregon | 97401 | — |
| Duramed Investigational Site | Medford | Oregon | 97504 | — |
| Duramed Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Duramed Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Duramed Investigational Site | Pittsburgh | Pennsylvania | 15206 | — |
| Duramed Investigational Site | Pottstown | Pennsylvania | 19464 | — |
| Duramed Investigational Site | Columbia | South Carolina | 29201 | — |
| Duramed Investigational Site | Hilton Head Island | South Carolina | 29926 | — |
| Duramed Investigational Site | Jackson | Tennessee | 38305 | — |
| Duramed Investigational Site | Houston | Texas | 77024 | — |
| Duramed Investigational Site | Waco | Texas | 76712 | — |
| Duramed Investigational Site | Williston | Vermont | 05495 | — |
| Duramed Investigational Site | Norfolk | Virginia | 23507 | — |
| Duramed Investigational Site | Seattle | Washington | 98105 | — |
| Duramed Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00782769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00782769 live on ClinicalTrials.gov.